Abstract
Bulk production of recombinant proteins and therapeutic vaccines largely depends on cellculture techniques. Suspension culture using microcarrier is a common manufacturing practice, despite its production limitations caused by shear force damage. Here we report a simple and scalable method to overcome this and improve the healthy cell mass. We hypothesized to curb the cell damage and increase the yield of cellular products through unique functionalization of microcarrier with an analog of peptide that is known to induce collagen and fibronectin like extracellular matrix (ECM) molecules. To test the hypothesis polystyrene beads (75-150 μm) were covalently grafted with HPLC purified peptide through spacer in a manner that produces ~ 4.2 micromole/g substitution. After UV and FTIR characterization, the functionalized beads (BSP), were evaluated by culturing Vero (African green monkey kidney) and MDCK (Madin-Darby canine kidney) cells. Microscopic study after 24 hours of culture exhibited cells in clusters over the beads and 81% of functionalized versus 41% unmodified beads (UB) were observed to be occupied by the cells. Alamar-blue assay confirmed that functionalization facilitates microcarrier to sustain more viable cells. Even with the present density of functional moiety, BSP sustained significantly (p<0.001) more viable cells in 24-30 hours in comparison to Cytodex, the most commonly used microcarrier. Thus, present technique provides an option to improve the number of healthy cells by stimulating a native mechanism in situ. Accomplished at room temperature, similar yet customized functionalization with defined moieties can potentially produce differentiated stem cells for tissue engineering and regenerative medicine.
Keywords: Alamar blue, extracellular matrix (ECM), functional peptides, MDCK, solid microcarrier, suspension culture, vero.
Graphical Abstract
Current Biotechnology
Title:Novel Functionalization for Maximizing Cell Turnover from Microcarrier
Volume: 3 Issue: 4
Author(s): B. Padmapriya, Sudip Ghosh, Nasreen Ehtesham, B. Sesikeran and Ranjna C. Dutta
Affiliation:
Keywords: Alamar blue, extracellular matrix (ECM), functional peptides, MDCK, solid microcarrier, suspension culture, vero.
Abstract: Bulk production of recombinant proteins and therapeutic vaccines largely depends on cellculture techniques. Suspension culture using microcarrier is a common manufacturing practice, despite its production limitations caused by shear force damage. Here we report a simple and scalable method to overcome this and improve the healthy cell mass. We hypothesized to curb the cell damage and increase the yield of cellular products through unique functionalization of microcarrier with an analog of peptide that is known to induce collagen and fibronectin like extracellular matrix (ECM) molecules. To test the hypothesis polystyrene beads (75-150 μm) were covalently grafted with HPLC purified peptide through spacer in a manner that produces ~ 4.2 micromole/g substitution. After UV and FTIR characterization, the functionalized beads (BSP), were evaluated by culturing Vero (African green monkey kidney) and MDCK (Madin-Darby canine kidney) cells. Microscopic study after 24 hours of culture exhibited cells in clusters over the beads and 81% of functionalized versus 41% unmodified beads (UB) were observed to be occupied by the cells. Alamar-blue assay confirmed that functionalization facilitates microcarrier to sustain more viable cells. Even with the present density of functional moiety, BSP sustained significantly (p<0.001) more viable cells in 24-30 hours in comparison to Cytodex, the most commonly used microcarrier. Thus, present technique provides an option to improve the number of healthy cells by stimulating a native mechanism in situ. Accomplished at room temperature, similar yet customized functionalization with defined moieties can potentially produce differentiated stem cells for tissue engineering and regenerative medicine.
Export Options
About this article
Cite this article as:
Padmapriya B., Ghosh Sudip, Ehtesham Nasreen, Sesikeran B. and Dutta C. Ranjna, Novel Functionalization for Maximizing Cell Turnover from Microcarrier, Current Biotechnology 2014; 3 (4) . https://dx.doi.org/10.2174/2211550104666150206233548
DOI https://dx.doi.org/10.2174/2211550104666150206233548 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Life and Death in the Placenta: New Peptides and Genes Regulating Human Syncytiotrophoblast and Extravillous Cytotrophoblast Lineage Formation and Renewal
Current Protein & Peptide Science Modified Envelope Glycoproteins to Retarget Retroviral Vectors
Current Gene Therapy Membrane Fusion Mediated Targeted Cytosolic Drug Delivery Through scFv Engineered Sendai Viral Envelopes
Current Molecular Medicine Comparative Proteomic Profiling of Extracellular Proteins between Normal and Gastric Cancer Cells
Current Cancer Drug Targets Passive Targeting of Cyclophosphamide-Loaded Carbonate Apatite Nanoparticles to Liver Impedes Breast Tumor Growth in a Syngeneic Model
Current Pharmaceutical Design Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Factors Regulating Human Extravillous Trophoblast Invasion: Chemokine-peptidase and CD9-integrin Systems
Current Pharmaceutical Biotechnology Genomic Organization and Control of the Grb7 Gene Family
Current Genomics Molecular Targets for the Treatment of Testicular Germ Cell Tumors
Mini-Reviews in Medicinal Chemistry Angiogenic and Vascular Modulation by Extracellular Matrix Cleavage Products
Current Pharmaceutical Design Prenatal Exposure of a Novel Antipsychotic Aripiprazole: Impact on Maternal, Fetal and Postnatal Body Weight Modulation in Rats
Current Drug Safety Recent Developments of Flavonoids with Various Activities
Current Topics in Medicinal Chemistry The Role and Therapeutic Potential of Ser/Thr Phosphatase PP2A in Apoptotic Signalling Networks in Human Cancer Cells
Current Molecular Medicine A Novel Approach to Anticancer Therapies: Peroxisome Proliferator Activator-Receptor-γ as a New Target Therapy in the Treatment of Human Urological Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design Molecular Basis of Gestational Trophoblastic Diseases
Current Molecular Medicine Bone Morphogenetic Protein-Smad Pathway as Drug Targets for Osteoporosis and Cancer Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets